Archer Capital | The National Business Review

Flaws in Labour’s 'Nazi' card, Queenstown’s convention centre wars, another possible tech listing and look who's penning Meridian research

Labour's lurch to the left will get a firm shove in the coming month.

Wed, 11 Jul 2018

Abano shares valued at $8.30-$10.05 by Grant Samuel, exceeding Archer price

Abano Healthcare [NZX: ABA] is worth $8.30 to $10.05 a share for 100 percent of the company, a premium of as much as 46 percent to recent

Wed, 11 Jul 2018

Enterprise division head Carolyn Luey says “We want to help more small businesses make that transition to being a bigger business.”

Premium

The part of MYOB that doesn’t compete with Xero is growing fast

“Whether it will ever be bigger than the small business and accounting part of our business, I don't really know, but it is one of the fastest growing,” says Carolyn Luey.

Jenny Ruth

Thu, 25 Jan 2018

Abano to sue biggest shareholder for takeover costs

Peter Hutson and James Reeves have been lobbying for change at Abano for several years.

BusinessDesk

Thu, 20 Apr 2017

FMA drops claim against Abano bidders Archer Capital and Healthcare Industry

The market watchdog filed papers against Archer and Hutson's Healthcare Industry vehicle in late 2014.

BusinessDesk

Fri, 15 Jul 2016

NZP managing director Richard Garland

NZ Pharmaceuticals gets $49.6m cash injection as Archer Capital takes over

Last week Direct Capital completed the sale of its 51% stake in NZP for an undisclosed sum to Archer.

BusinessDesk

Mon, 11 Apr 2016

Aspire2 chief executive Sussan Turner

Premium

Former MediaWorks chief joins private equity backed roll-up

Archer Capital launches $190m education group Aspire2.

Tim Hunter

Tue, 03 Nov 2015

FMA files civil proceedings relating to failed Abano takeover

The Financial Markets Authority has pounced on Peter Hutson’s failed takeover attempt of Abano Healthcare [NZX: ABA] and filed civ

Fri, 03 Oct 2014

Archer consortium terminates Abano ‘bid’, looks to oust chairman

Two investors backed by private equity firm Archer Capital have withdrawn a proposed takeover bid for Abano Healthcare [NZX: ABA] , blaming

Thu, 28 Nov 2013

Lumino publicity image

Premium

Abano offer flushes out third parties, says Janes

Tue, 26 Nov 2013

© 2019 NBR. All rights reserved.

Design by \ nero motion